Business Wire

FOURKITES

Share
3T-FourKites Partnership Offers Enhanced Cost and Sustainability Benefits to Customers

Leading real-time supply chain visibility platform FourKites ® today announces that its carrier data will be used to enhance 3T’s global digital transport platform.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220823005400/en/

The deal will give 3T’s shipper customers access to FourKites’ supply chain visibility data, bringing them powerful flexibility in the way they use carriers, thereby reducing costs and improving sustainability initiatives.

“FourKites’ broad coverage of carriers in Europe allows us to give our customers a more comprehensive shipment visibility offering as part of our digital transport management software,” says Rob Hutton, Group Sales and Marketing Director at 3T. “That gives them more flexibility in the carriers they can work with, keeping both costs and carbon emissions down.”

3T is a UK-based global SaaS digital transport platform provider, whose transport management solutions dovetail neatly with FourKites’ supply chain visibility offering. 3T’s pioneering cloud-based platform provides a seamless shipper/carrier ecosystem with functionality including transport assignment, rate management and tendering, as well as automatic carrier allocation. It also facilitates supply chain collaboration by enabling AI-driven dynamic planning and execution across multiple accounts, harnessing real-time data to reduce empty running of vehicles.

FourKites is the market leader in real-time, end-to-end supply chain visibility, extending visibility beyond transportation into yards, warehouses, stores and more. The companies’ combined offering signals a paradigm shift in 3T’s ability to not only know the status and position of every shipment, but to also dynamically react to changes from plan.

“Giving 3T customers access to FourKites data will allow them to make better decisions, optimising the way they use carriers,” says Marc Boileau, Senior VP of Sales and Carrier Operations at FourKites Europe. “That has cost benefits for them, it improves their service to customers with almost no administrative work required, and it gives them the most accurate estimated times of arrival available in the market today. We are thrilled to be working together with the 3T team to better support their customer base.”

Carbon reductions

3T already gives customers multiple options to capture carrier data. However, with the addition of FourKites’ real-time supply chain data, 3T customers will now have all the data necessary to complete their operational visibility picture and ultimately help them reduce both carbon emissions and costs through improved resource utilisation.

“We see a huge efficiency opportunity for both shippers and carriers by using data to identify and reduce empty running across the industry. This will be essential to meet our collective environmental targets,” says Rob, "and it’s why this partnership is so exciting for us.”

This is just one aspect of the improved planning shippers can achieve with the 3T-FourKites partnership.

“You’re likely to get a good price by placing a shipment on an empty running truck,” says Marc, “so costs go down. But carriers have fewer empty runs, too, so they see driver productivity improve. It’s win-win. The better your visibility, the better you can plan to optimise your transport.”

In March, FourKites announced its Sustainability Hub, which offers granular emissions tracking, industry benchmarks, analytics and scenario modeling to help customers meet sustainability goals. In addition, the company offers Dynamic Yard ® , a new category of software that connects traditional, siloed yard management software with FourKites’ real-time supply chain data and predictive ETAs to provide insight into driver detention patterns, labor efficiency and more to reduce dwell and inform carbon reduction strategies. Last year, customers who used Dynamic Yard emitted 20% fewer carbon emissions than non-Dynamic Yard users through reductions in truck idle times.

Notes for editors

About FourKites®

Leading global supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching more than 200 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,100 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit www.fourkites.com .

About 3T

3T Logistics and Technology Group is an award-winning UK head-quartered SaaS transport management technology business with clients including JCB, Klockner Pentaplast and Kraft Heinz. Founded in 2000 as a 4th Party Logistics Provider (4PL), 3T has evolved to become a globally recognised transportation management (TMS) technology provider. The company’s vision and mission remain the same since its inception, to improve service, reduce cost to shippers and carriers and remove empty running through collaboration and the smart use of technology.

To learn more about 3T please visit their website: https://www.3t-ltg.com/

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release

The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki

Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release

Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release

Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release

SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye